Phase II Trial of SMO/AKT/NF2 Inhibitors in Progressive Meningiomas with SMO/AKT/NF2 Mutations - Regional Cancer Care Associates LLC

Clinical Trials

Phase II Trial of SMO/AKT/NF2 Inhibitors in Progressive Meningiomas with SMO/AKT/NF2 Mutations

Type of Cancer
Neuro-Oncology
Locations
Hackensack
Sponsor
Alliance
Protocol Number
A071401
Cancer Diagnosis
To Learn More Call
201-510-0910